STOCK TITAN

Jazz Pharmaceuticals' 2022 Corporate Sustainability and Social Impact Report: Using Natural Resources Responsibly

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary
Jazz Pharmaceuticals (JAZZ) Corporate Sustainability and Social Impact Report 2022: Environmental Responsibility, Climate Strategy, and Water Management
Positive
  • None.
Negative
  • None.

NORTHAMPTON, MA / ACCESSWIRE / November 29, 2023 / Jazz Pharmaceuticals

Originally Published in Jazz Pharmaceuticals' 2022 Corporate Sustainability and Social Impact Report

Management Approach

We seek to operate our business in an environmentally responsible way and are committed to meeting evolving regulatory standards and taking steps to reduce our environmental impact, using sustainable practices wherever feasible.

Our use of natural resources, including energy and water, is of material importance to our business. We continue to make incremental improvements to our environmental footprint on a site-by-site basis. In addition to having environmental management systems across our manufacturing operations sites, we continue to identify opportunities to reduce our environmental footprint in relation to greenhouse gas emissions, energy consumption, water use and waste generation and disposal.

While we have made progress in this area, we recognize our responsibility to act to quickly reduce our emissions and use of natural resources. Alongside our Environmental Management Systems, we are committed to improving our data collection frameworks and reporting across our CSSI strategy, including environmental performance. Establishing robust datasets and frameworks will allow us to set targets to hold ourselves accountable and ensure we are improving our environmental performance over time.

Environmental Management Systems

Our global sustainability practices guide resource management throughout our operations and are enacted at the site level through individual environmental management system (EMS) programs. Our harmonized EMS programs support Jazz's efforts to enhance our environmental performance and assist us in achieving environmental sustainability objectives through continuous monitoring of our energy use, waste generation, water use, water discharges and emissions. This proactive EMS approach also helps reduce the risk of non-compliance and improves health and safety practices for employees and the public.

Our Villa Guardia site maintains an EMS certified to the ISO 14001:2015 standard and Eco-Management and Audit Scheme Regulation.

Jazz maintains environmental policies across our manufacturing and development operations to comply with applicable laws, directives and regulations on environmental protection and sustainability.

Climate & Energy

We recognize our responsibility to minimize our contribution to climate change by reducing the greenhouse gas (GHG) emissions associated with our business activities. While we are focused on delivering life-changing solutions for our patients, we must also play a role in addressing climate change by minimizing our impact on the planet. To this end, we are developing a comprehensive approach to tracking and reducing our GHG emissions. This begins with measuring our Scope 1 and 2 GHG emissions, a process that we started in 2022. We are beginning a journey to set emissions reduction targets and track our improvement over time.

While we have been implementing initiatives across our facilities to minimize our energy use, and corresponding GHG emissions, we are now formalizing our climate strategy by calculating our baseline emissions figures. We will establish a strategy to reduce emissions over the course of 2023 and will publicly disclose our progress once our ambition is set.

Water Use and Management

Water is a finite and vital resource for our planet and the communities where we operate. We recognize the importance of responsible water management within our business activities and are committed to reducing water consumption across our operations by implementing efficient water management practices.

In 2022, both our Athlone and Villa Guardia manufacturing and development sites purchased and consumed renewable electricity.

  • Athlone: 100% Renewable Electricity
  • Villa Guardia: 52% Renewable Electricity

Our Athlone, Kent Science Park, and Villa Guardia manufacturing sites have implemented energy efficiency and conservation measures, including LED light conversions and energy efficient chiller replacements, as well as installations of electric vehicle charging stations.

Waste Management and Disposal

We continuously strive to reduce consumption of materials and minimize quantities of waste generated by our facilities. Wherever possible, we separate and recycle waste and dispose of any toxic, hazardous and biological materials according to regulatory requirements.

Read more about Jazz Pharmaceuticals' commitment to our planet in its 2022 Corporate Sustainability and Social Impact Report.

As a neighbor to The River Shannon, the longest river in Ireland and the British Isles, Jazz participates in protection efforts in the surrounding area.

View additional multimedia and more ESG storytelling from Jazz Pharmaceuticals on 3blmedia.com.

Contact Info:
Spokesperson: Jazz Pharmaceuticals
Website: https://www.3blmedia.com/profiles/jazz-pharmaceuticals
Email: info@3blmedia.com

SOURCE: Jazz Pharmaceuticals



View source version on accesswire.com:
https://www.accesswire.com/811267/jazz-pharmaceuticals-2022-corporate-sustainability-and-social-impact-report-using-natural-resources-responsibly

FAQ

What is the focus of Jazz Pharmaceuticals' 2022 Corporate Sustainability and Social Impact Report?

The report focuses on environmental responsibility, climate strategy, and water management.

What is Jazz Pharmaceuticals' ticker symbol?

The ticker symbol for Jazz Pharmaceuticals is JAZZ.

How is Jazz Pharmaceuticals seeking to reduce its environmental impact?

Jazz Pharmaceuticals is committed to reducing its environmental impact by using sustainable practices, minimizing greenhouse gas emissions, and implementing efficient water management practices.

What is Jazz Pharmaceuticals doing to minimize its contribution to climate change?

Jazz Pharmaceuticals is developing a comprehensive approach to tracking and reducing its greenhouse gas emissions, as well as setting emissions reduction targets and publicly disclosing its progress.

What percentage of renewable electricity did Jazz Pharmaceuticals' Athlone manufacturing site purchase and consume in 2022?

Jazz Pharmaceuticals' Athlone manufacturing site purchased and consumed 100% renewable electricity in 2022.

What measures has Jazz Pharmaceuticals implemented to reduce energy use and corresponding greenhouse gas emissions?

Jazz Pharmaceuticals has implemented energy efficiency and conservation measures, including LED light conversions and energy-efficient chiller replacements, as well as installations of electric vehicle charging stations.

Jazz Pharmaceuticals, Inc.

NASDAQ:JAZZ

JAZZ Rankings

JAZZ Latest News

JAZZ Stock Data

6.89B
60.45M
2.82%
95.89%
5.23%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
DUBLIN

About JAZZ

jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni